Great post Dazzer AND Eire.
They may be different, but no-one sensible could say they're not well thought out and argued.
There's no doubt that Adapt sales have been excruciatingly slow so far.
Having said that though, the achievements of 2017 (TAVR patents lodged, regulatory approval for India, establishment of the 3D platform, commencement of nRAH contract, 4c contract, loan from PFG, WP signing on for 3 years) are MASSIVE.
Personally I'm happy to buy the "hockey-stick" theorem for late 2018 Adapt sales for now. But I'll also be disappointed if US GPO tenders come to nothing.
Meanwhile - TAVR progress, immunotherapies deal, new 3D products, approval of Chinese registration study, Australian TGA approval, new Adapt products, new engineering products, new Aust. hospital tenders... are all in the pipeline as well.
All yours for 25c.
Keep up the intelligent posting.
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-103
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.25 |
Change
-0.250(2.17%) |
Mkt cap ! $238.8M |
Open | High | Low | Value | Volume |
$11.50 | $11.50 | $11.00 | $241.7K | 21.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 189 | $11.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.37 | 78 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 174 | 11.310 |
2 | 174 | 11.220 |
1 | 88 | 11.210 |
3 | 596 | 11.200 |
1 | 208 | 11.190 |
Price($) | Vol. | No. |
---|---|---|
11.370 | 78 | 2 |
11.490 | 640 | 1 |
11.500 | 5434 | 2 |
11.830 | 500 | 1 |
11.850 | 164 | 1 |
Last trade - 10.54am 16/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online